R. Endele

1.0k total citations
20 papers, 784 citations indexed

About

R. Endele is a scholar working on Pharmacology, Analytical Chemistry and Spectroscopy. According to data from OpenAlex, R. Endele has authored 20 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Analytical Chemistry and 5 papers in Spectroscopy. Recurrent topics in R. Endele's work include Analytical Methods in Pharmaceuticals (6 papers), Analytical Chemistry and Chromatography (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). R. Endele is often cited by papers focused on Analytical Methods in Pharmaceuticals (6 papers), Analytical Chemistry and Chromatography (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). R. Endele collaborates with scholars based in Germany, United States and Switzerland. R. Endele's co-authors include I. Halász, U. Abshagen, Frieder Bauss, Klaus K. Unger, B. Kaufmann, Martin Senn, G Betzien, Gerda Rudolph, Adolf Stiehl and Ludwig A. Hothorn and has published in prestigious journals such as Hepatology, Journal of Pharmacology and Experimental Therapeutics and Journal of Chromatography A.

In The Last Decade

R. Endele

20 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Endele Germany 13 290 225 198 180 170 20 784
Roland Heinig Germany 17 76 0.3× 47 0.2× 357 1.8× 407 2.3× 68 0.4× 57 1.3k
D. Moore United Kingdom 13 66 0.2× 71 0.3× 105 0.5× 100 0.6× 10 0.1× 19 702
Lawrence S. Olanoff United States 17 158 0.5× 65 0.3× 123 0.6× 91 0.5× 82 0.5× 27 823
Jean‐Paul Cano France 18 69 0.2× 52 0.2× 242 1.2× 341 1.9× 77 0.5× 39 919
Jin Q Kim South Korea 18 38 0.1× 44 0.2× 161 0.8× 55 0.3× 17 0.1× 55 1.1k
Szilvia Mészáros Hungary 13 265 0.9× 167 0.7× 90 0.5× 52 0.3× 69 0.4× 36 568
Nikolaos Tsamandouras United States 13 46 0.2× 216 1.0× 177 0.9× 189 1.1× 21 0.1× 20 874
Oliver Scherf‐Clavel Germany 16 62 0.2× 73 0.3× 176 0.9× 149 0.8× 58 0.3× 61 771
T. Ikeda Japan 15 24 0.1× 28 0.1× 202 1.0× 233 1.3× 14 0.1× 29 889
Marina De Smet United States 17 87 0.3× 32 0.1× 132 0.7× 183 1.0× 95 0.6× 21 1.1k

Countries citing papers authored by R. Endele

Since Specialization
Citations

This map shows the geographic impact of R. Endele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Endele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Endele more than expected).

Fields of papers citing papers by R. Endele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Endele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Endele. The network helps show where R. Endele may publish in the future.

Co-authorship network of co-authors of R. Endele

This figure shows the co-authorship network connecting the top 25 collaborators of R. Endele. A scholar is included among the top collaborators of R. Endele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Endele. R. Endele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Endele, R., et al.. (2005). Analytical methods for the quantification of ibandronate in body fluids and bone. Journal of Pharmaceutical and Biomedical Analysis. 39(1-2). 246–256. 27 indexed citations
2.
Bauss, Frieder, et al.. (2002). Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats.. PubMed. 29(10). 2200–8. 74 indexed citations
3.
Meyer, Kirstin, et al.. (1999). Species differences in induction of hepatic enzymes by BM 17.0744, an activator of peroxisome proliferator-activated receptor alpha (PPARα). Archives of Toxicology. 73(8-9). 440–450. 23 indexed citations
4.
Sauer, Peter, G Rudolph, R. Endele, et al.. (1996). Kinetics of primary bile acids in patients after orthotopic liver transplantation. European Journal of Clinical Investigation. 26(11). 979–982. 9 indexed citations
5.
Rudolph, Gerda, R. Endele, Martin Senn, & Adolf Stiehl. (1993). Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis. Hepatology. 17(6). 1028–1032. 41 indexed citations
6.
Stiehl, Adolf, Gerda Rudolph, R. Raedsch, et al.. (1990). Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology. 12(3). 492–497. 102 indexed citations
7.
Patscheke, H., G. Neugebauer, B. Kaufmann, et al.. (1986). Single dose pharmacokinetics and effects on platelet function of the thromboxane receptor blocker BM 13.177. European Journal of Clinical Pharmacology. 29(5). 573–579. 9 indexed citations
8.
Patscheke, H., C Staiger, G. Neugebauer, et al.. (1986). The pharmacokinetic and pharmacodynamic profiles of the thromboxane A-2 receptor blocker BM 13.177. Clinical Pharmacology & Therapeutics. 39(2). 145–150. 13 indexed citations
9.
Abshagen, U., G Betzien, R. Endele, B. Kaufmann, & G. Neugebauer. (1985). Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration. European Journal of Clinical Pharmacology. 27(6). 637–644. 25 indexed citations
10.
Sponer, G., et al.. (1984). Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.. Journal of Pharmacology and Experimental Therapeutics. 228(1). 235–239. 11 indexed citations
11.
Endele, R. & Martin Senn. (1983). MS/MS in pharmacokinetic studies. International Journal of Mass Spectrometry and Ion Physics. 48. 81–84. 5 indexed citations
12.
Endele, R., Martin Senn, & U. Abshagen. (1982). Determination of deacetylmetipranolol in body fluids by gas chromatography—chemical-ionization mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 227(1). 187–192. 8 indexed citations
13.
Endele, R., et al.. (1981). High performance liquid chromatographic method for determination of canrenone in serum. Journal of High Resolution Chromatography. 4(8). 419–421. 4 indexed citations
14.
Abshagen, U., et al.. (1981). [Pharmacokinetics, effect and tolerance of isosorbide dinitrate and isosorbide-5-mononitrate in healthy persons].. PubMed. 32(14A). 508–16. 8 indexed citations
15.
Abshagen, U., G Betzien, R. Endele, & B. Kaufmann. (1981). Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate. European Journal of Clinical Pharmacology. 20(4). 269–275. 71 indexed citations
16.
Abshagen, U., et al.. (1979). Kinetics of canrenone after single and multiple doses of spironolactone. European Journal of Clinical Pharmacology. 16(4). 255–262. 32 indexed citations
17.
Endele, R.. (1978). A gas chromatographic method for the determination of Bezafibrate in serum and urine. Journal of Chromatography A. 154(2). 261–263. 20 indexed citations
18.
Halász, I., et al.. (1975). Ultimate limits in high-pressure liquid chromatography. Journal of Chromatography A. 112. 37–60. 205 indexed citations
19.
Endele, R., et al.. (1975). Hochdruckflüssigchromatographische Bestimmung von Allopurinol und Oxipurinol in Serum. Journal of Chromatography A. 115(1). 228–231. 16 indexed citations
20.
Endele, R., et al.. (1974). Influence of the particle size (5–35 μm) of spherical silica on column efficiencies in high-pressure liquid chromatography. Journal of Chromatography A. 99. 377–393. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roland Heinig Breakdown of academic impact, for papers by D. Moore Breakdown of academic impact, for papers by Lawrence S. Olanoff Breakdown of academic impact, for papers by Jean‐Paul Cano Breakdown of academic impact, for papers by Jin Q Kim Breakdown of academic impact, for papers by Szilvia Mészáros Breakdown of academic impact, for papers by Nikolaos Tsamandouras Breakdown of academic impact, for papers by Oliver Scherf‐Clavel Breakdown of academic impact, for papers by T. Ikeda Breakdown of academic impact, for papers by Marina De Smet
Rankless by CCL
2026